Article
A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae.
Microbiology spectrum - 6 Aug 2024
Qiao Sai, Xin Shaojun, Zhu Yufeng, Zhao Feng, Wu Heng, Zhang Jingjing, Yao Bingyan, Yu Yunsong, Fu Ying, Jiang Yan, Xie Xinyou, Zhang Jun
Abstract excerpt
To monitor the resistance rate and gain a deeper understanding of the resistance mechanisms, we conducted over a 2-year surveillance focusing on the Klebsiella pneumoniae associated with the clinical usage of ceftazidime-avibactam (CZA) in a teaching hospital. A total of 4,641 K. pneumoniae isolates were screened to identify the CZA resistance through antimicrobial susceptibility testing. Comprehensive analyses,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
